- Home
- LEGN
as 11-15-2024 4:00pm EST
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 9.1B | IPO Year: | 2020 |
| Target Price: | $81.46 | AVG Volume (30 days): | 1.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.92 | EPS Growth: | N/A |
| 52 Week Low/High: | $38.02 - $70.13 | Next Earning Date: | 11-12-2024 |
| Revenue: | $520,183,000 | Revenue Growth: | 122.96% |
| Revenue Growth (this year): | 110.04% | Revenue Growth (next year): | 77.16% |
Latest Legend Biotech Corporation News
LEGN Breaking Stock News: Dive into LEGN Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Legend Biotech Corporation (NASDAQ:LEGN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
Simply Wall St.
3 days ago
Legend Biotech Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Thomson Reuters StreetEvents
4 days ago
Q3 2024 Legend Biotech Corp Earnings Call
GuruFocus.com
4 days ago
Legend Biotech Corp (LEGN) Q3 2024 Earnings Call Highlights: CARVYKTI's Impressive Growth Amid ...
Zacks
5 days ago
Legend Biotech (LEGN) Reports Q3 Earnings: What Key Metrics Have to Say
MT Newswires
5 days ago
Legend Biotech Q3 Loss Widens, Revenue Rises
GlobeNewswire
5 days ago
Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights
Zacks
6 days ago
Legend Biotech (LEGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Compare LEGN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LEGN Legend Biotech Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.